AAAAAA
Results:
1-8
|
Results: 8
Authors:
Feigelson, HS
Rodriguez, C
Robertson, AS
Jacobs, EJ
Calle, EE
Reid, YA
Thun, MJ
Citation: Hs. Feigelson et al., Determinants of DNA yield and quality from buccal cell samples collected with mouthwash, CANC EPID B, 10(9), 2001, pp. 1005-1008
Authors:
McKean-Cowdin, R
Feigelson, HS
Pike, MC
Coetzee, GA
Kolonel, LN
Henderson, BE
Citation: R. Mckean-cowdin et al., Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype, CANCER RES, 61(3), 2001, pp. 848-849
Authors:
Feigelson, HS
McKean-Cowdin, R
Coetzee, GA
Stram, DO
Kolonel, LN
Henderson, BE
Citation: Hs. Feigelson et al., Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates, CANCER RES, 61(2), 2001, pp. 785-789
Authors:
Feigelson, HS
Henderson, BE
Citation: Hs. Feigelson et Be. Henderson, Future possibilities in the prevention of breast cancer - Role of genetic variation in breast cancer prevention, BREAST CA R, 2(4), 2000, pp. 277-282
Authors:
McKean-Cowdin, R
Feigelson, HS
Ross, RK
Pike, MC
Henderson, BE
Citation: R. Mckean-cowdin et al., Declining cancer rates in the 1990s, J CL ONCOL, 18(11), 2000, pp. 2258-2268
Authors:
Henderson, BE
Feigelson, HS
Citation: Be. Henderson et Hs. Feigelson, Hormonal carcinogenesis, CARCINOGENE, 21(3), 2000, pp. 427-433
Authors:
Feigelson, HS
McKean-Cowdin, R
Pike, MC
Coetzee, GA
Kolonel, LN
Nomura, AMY
Le Marchand, L
Henderson, BE
Citation: Hs. Feigelson et al., Cytochrome P450c17 alpha gene (CYP17) polymorphism predicts use of hormonereplacement therapy, CANCER RES, 59(16), 1999, pp. 3908-3910
Authors:
Feigelson, HS
Henderson, BE
Citation: Hs. Feigelson et Be. Henderson, Estrogens and breast cancer - An epidemiologic perspective, CONT ENDOC, 11, 1999, pp. 55-67
Risultati:
1-8
|